Suppr超能文献

生物标志物在呼吸疾病中的应用

Biological Biomarkers in Respiratory Diseases.

机构信息

Servicio de Neumología, Hospital Universitario la Paz-IdiPAZ, Madrid, España; CIBER de enfermedades respiratorias, ISCIII, Madrid, España.

CIBER de enfermedades respiratorias, ISCIII, Madrid, España; Servicio de Neumología, Hospital Virgen de las Nieves, Granada, España.

出版信息

Arch Bronconeumol. 2022 Apr;58(4):323-333. doi: 10.1016/j.arbres.2022.01.003. Epub 2022 Jan 17.

Abstract

In recent years, personalized or precision medicine has made effective inroads into the management of diseases, including respiratory diseases. The route to implementing this approach must invariably start with the identification and validation of biological biomarkers that are closely related to the diagnosis, treatment, and prognosis of respiratory patients. In this respect, biological biomarkers of greater or lesser reliability have been identified for most respiratory diseases and disease classes, and a large number of studies are being conducted in the search for new indicators. The aim of this review is to update the reader and to analyze the existing scientific literature on the existence and diagnostic, therapeutic, and prognostic validity of the most important biological biomarkers in the main respiratory diseases, and to identify future challenges in this area.

摘要

近年来,个性化或精准医学在疾病管理方面取得了显著进展,包括呼吸系统疾病。实施这一方法的途径必须始终从确定和验证与呼吸系统患者的诊断、治疗和预后密切相关的生物标志物开始。在这方面,已经确定了大多数呼吸系统疾病和疾病类别的可靠性不同的生物标志物,并且正在进行大量研究以寻找新的指标。本文的目的是更新读者,并分析主要呼吸系统疾病中最重要的生物标志物的存在以及其在诊断、治疗和预后方面的有效性的现有科学文献,并确定该领域未来的挑战。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验